Loading news...
Ascentage Pharma raised $150M Series C venture round, led by Teng Yue Partners.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$237.6M
Top Valuation
-
Ascentage Pharma raised $150M in a Series C round.
The round was announced on 07/18/18.
The round was led by Teng Yue Partners, Lawrence Tian.